Akili, Inc.
DelistedCIK 1850266fmd_0HF0YJKBZZJJN3D9RVN4AKDGVRManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2021 to Mar 31, 2024, 12 periods
| Line item | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
| Total revenues | 1 | 0 | 2 |
| Cost of revenue | 0 | 0 | 1 |
| Gross profit | 0 | (0) | 1 |
| Research and development | 18 | 29 | 20 |
| Selling, general and administrative | 43 | 62 | 45 |
| Total operating expenses | 61 | 91 | 65 |
| Operating income | (61) | (91) | (64) |
| Interest expense | 0 | 1 | 2 |
| Other non-operating income (expense) | (1) | 83 | 5 |
| Income before taxes | (61) | (8) | (59) |
| Income tax expense | – | 0 | 0 |
| Net income from continuing operations | (61) | (8) | (59) |
| Net income | (61) | (8) | (59) |
| Net income to common shareholders | (127) | (19) | (59) |